Clinical Trial Update: Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Epidiolex (cannabidiol) in biochemically recurrent prostate cancer has completed with results posted. The study investigates safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Zin W Myint | Conditions: Prostate Cancer Recurrent, Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2025-03-05